A year after 'Liberation Day,' Trump sets new drug tariffs, adjusts metals duties

President Trump ordered 100% tariffs on certain branded pharmaceutical imports and overhauled duties on steel, aluminum and copper, reversing last year’s broader global tariff collapse. The move materially raises cost risk for pharmaceutical firms relying on imported inputs and will affect industrials and metals-exposed sectors via altered duty regimes. Expect sector-level disruption and upward pressure on input costs, with potential negative earnings implications for affected companies.

Analysis

President Trump ordered 100% tariffs on certain branded pharmaceutical imports and overhauled duties on steel, aluminum and copper, reversing last year’s broader global tariff collapse. The move materially raises cost risk for pharmaceutical firms relying on imported inputs and will affect industrials and metals-exposed sectors via altered duty regimes. Expect sector-level disruption and upward pressure on input costs, with potential negative earnings implications for affected companies.